Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study

NCT03433885 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2021-02-24

No results posted yet for this study

Summary

To evaluate the correlation between macular pigment optical density (MPOD) levels and risk of progression in patients with age-related macular degeneration

Conditions

  • Macular Pigment Optical Density

Sponsors & Collaborators

  • The Eye Hospital of Wenzhou Medical University

    lead OTHER

Principal Investigators

  • Xiaoling Liu, MD · The Eye Hospital of Wenzhou Medical University

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2021-12-31
Completion
2023-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03433885 on ClinicalTrials.gov